Surgery Partners, Inc. (SGRY) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

NEW YORK CITY, NY / ACCESS Newswire / November 23, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Surgery Partners, Inc. ("Surgery Partners" or "the Company") (NASDAQ:SGRY). Investors who purchased Surgery Partners securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/SGRY.

Logo, company nameDescription automatically generated

Investigation Details

On November 10, 2025, Surgery Partners issued a press release announcing its financial results for the third quarter of 2025 and held an earnings call to discuss the same. The Company lowered its full-year revenue guidance to a range of $3.275 billion to $3.3 billion, and its adjusted EBITDA guidance to a range of $535 million to $540 million. Surgery Partners’ management attributed the guidance revision to timing delays in capital deployment, lost earnings from ambulatory surgical center divestitures, and a cautious stance on commercial payer mix and volume in the fourth quarter. Following this news, Surgery Partners’ stock price dropped $5.47 per share, or 25.42%, to close at $16.04 on November 10, 2025.

What’s Next?

If you are aware of any facts relating to this investigation or purchased Surgery Partners securities, you can assist this investigation by visiting the firm’s site: bgandg.com/SGRY. You can also contact Peretz Bronstein or his client relations manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC: 332-239-2660

There is No Cost to You

We represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys’ fees, usually a percentage of the total recovery, only if we are successful.

Why Bronstein, Gewirtz & Grossman

Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.

Follow us for updates on LinkedIn, X, Facebook, or Instagram.

Attorney advertising. Prior results do not guarantee similar outcomes.

Contact

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Nathan Miller
332-239-2660 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

View the original press release on ACCESS Newswire

comtex tracking

COMTEX_470495511/2457/2025-11-23T11:15:11

Scroll to Top